SEQUENOM Announces Resignation of CEO Schuh
Dr. Schuh will remain as a consultant to the Company for up to 12 months. No one has been appointed to fill the vacancy on the Board created by Dr. Schuh's resignation.
Dr. Schuh joined SEQUENOM's German subsidiary as Managing Director in December 1996. In 1998, he moved to the Company's San Diego headquarters to serve as Executive Vice President of Business Development. In May 2000, Dr. Schuh became President and Chief Executive Officer and was elected to the Board.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.